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Introduction 
Patients with anosognosia have been presented more dangerous behaviours and difficulties 
with treatment adherence, leading to increased burden on caregivers (Conde-Sala et al., 
2015). Anosognosia Questionnaire for Dementia (AQ-D; Migliorelli et al., 1995) has been 
used to collect patients and caregivers’ perceptions about anosognosia. A factor analysis of 
the AQ-D produced two factors: lack of awareness of cognitive deficits and behavioural 
symptoms (Starkstein et al., 2006). However, when we considered Alzheimer’s disease (AD) 
diagnostic criteria from American Psychiatric Association, whose principal aspects are 
cognition, functionality and behaviour/personality; those two factors proposed may not be 
enough to analyse anosognosia.  
We investigated the factorial structure of the AQ-D from a clinical perspective. 
Specifically, the objectives were to examine: 1. the discrepancies between patients and 
caregivers in AQ-D clinical factors, and 2. the association between the AQ-D clinical factors, 
and sociodemographic and clinical characteristics of patients and caregivers.  
 
Methods 
Design and study population 
Cross-sectional study using 221 patients and their caregivers from Bellvitge University 
Hospital were included.  
 
Variables and instruments 
Patients evaluated their cognition and anosognosia level (AQ-D; Migliorelli et al., 1995). 
Caregivers evaluated patients’ variables (age, gender, marital status, education, family 
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relationship, anosognosia, functionality, depression, neuropsychiatric symptoms and dementia 
severity) and had caregiver burden, physical and mental health assessed.  
 
Statistical analysis 
Wilcoxon test determined the differences between caregivers and patients’ AQ-D scores and 
Cohen’s d measured the effect size in these differences. Spearman’s correlations explored the 
relationship between AQ-D and patients and caregivers’ variables.  
A principal components analysis for the AQ-D was carried out with rotation (varimax). 
To verify clinical perspective, the researchers grouped the 30 items of the AQ-D on three 
factors. Variance and Cronbach's alpha for each factor estimated contribution and internal 
consistency. Two multiple linear regression analyses were performed to determine the 
influence of the independent variables on existence of anosognosia. 
The level of significance for comparisons was p < 0.05. SPSS v22.0 for Windows 
(SPSS Inc., Chicago) was used to statistical analysis.  
 
 
Results 
Most patients were females (63.3%), with mean age of 77.8 ± 6.3 years, with formal 
education > five years (36.7%), and with a mean MMSE score of 18.3 ± 5.4.  
Cronbach’s alpha was high (α = 0.91), indicating excellent internal consistency. Three 
factors were grouped: 1 Cognition, 2 Functionality, and 3 Behaviour/Personality. In the 
multivariate analysis, to patients, the factor Functionality was the most relevant in the 
association between high levels of anosognosia and deficits in activities of daily living 
(ADLs) (p < 0.001), less depressive symptoms (p < 0.001), more neuropsychiatric symptoms 
(p < 0.001), and older patients (p = 0.012). To caregivers, the factor Personality was the most 
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important in the relationship between high levels of anosognosia and caregiver burden (p < 
0.001) and female gender (p = 0.022). 
 
Discussion  
Factor 1 Cognition presented high Cronbach’s alpha (α = 0.84), indicating good to excellent 
internal consistency of the scale. Cronbach’s alpha was moderate in Factor 2 Functionality (α 
= 0.77), and Factor 3 Behaviour/Personality (α = 0.70). Our results may suggest a relative 
independence between anosognosia levels for different abilities (Starkstein et al., 2006).  
The highest discrepancy between patients and caregivers in AQ-D clinical factors 
occurred in factor 1 Cognition. Correa et al. (1996) indicated that AD patients showed 
anosognosia of the severity of their memory decline on a questionnaire and made fewer self-
corrections. 
AQ-D clinical factor varied according to the rater in the present study, to patients was 
factor 2 Functionality that was influenced by deficits in ADLs. This finding deserves 
attention, because functionality scores predicted the scores for the domains of anosognosia of 
functional deficits on the AQ-D clinical factor (Starkstein et al., 2006). Likewise, another 
consensus in literature is a higher frequency of neuropsychiatric symptoms in the 
anosognosia, and our study is in line with this finding (Conde-Sala et al., 2015). Furthermore, 
we suggested that less depressive symptoms in patients with AD were associated with high 
levels of anosognosia. The presence of low levels of depression may mean non-awareness of 
deficits (Portellano-Ortiz et al., 2014). While to caregivers, the factor was 3 
Behaviour/Personality. Higher discrepancies of anosognosia between patients and caregivers 
have been mostly correlated with neuropsychiatric symptoms. Moreover, the presence of 
more neuropsychiatric symptoms and anosognosia were related to caregiver burden (Conde-
Sala et al., 2015). 
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Finally, our findings indicated that in a clinical perspective, the grouping of AQ-D items 
on three factors Cognition, Functionality and Behaviour/Personality was consistent. Also, we 
confirmed that anosognosia is multidimensional phenomenon that it is in agreement with AD 
diagnostic criteria.  
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Table 1  Multivariate Linear Regression Analysis: AQ-D clinical factors and patients and caregivers’ variables 
      DAD NPI GDS-d Age 
  
Patients R2 β          t           p β           t            p β      t       p β        t           p 
AQ-D total  0.666 -0.51   -10.9 < 0.001 0.34     7.4   < 0.001 -0.31 -8.0 < 0.001 0.09    2.4     0.014 
 Factor 1 0.559 -0.51 -9.5 < 0.001 0.25 4.7 < 0.001 -0.30 -6.6 < 0.001 0.10 2.2 0.023 
 Factor 2 0.596 -0.54 -10.5 < 0.001 0.25 5.0  < 0.001 -0.28 -6.5 < 0.001 0.01 2.5 0.012 
 Factor 3 0.460 -0.24 -4.0 < 0.001 0.47 8.1 < 0.001 -0.25 -5.0 < 0.001 0.02 0.5 0.585 
 
       ZBI Gender (women) Age   
Caregivers R2 β        t          p β t      p β            t            p  
AQ-D Total 0.299 0.50 8.7 < 0.001 0.14 2.3  0.019 0.13 2.3   0.021    
 Factor 1 0.220 0.42 6.9 < 0.001 0.14 2.2  0.023 0.15 2.4  0.016 
 Factor 2 0.226 0.45 7.4 < 0.001 0.09 1.4  0.140 0.11 1.8  0.068 
 Factor 3 0.305 0.51 8.9 < 0.001 0.13 2.3  0.022 0.07 1.3  0.185 
Factor 1: Cognition; Factor 2: Functionality; Factor 3: Behaviour/Personality. 
R2 = Determination coefficient; β = standardized beta coefficient; t = Students t, test. 
AQ-D: Anosognosia Questionnaire for Dementia; DAD: Disability Assessment for Dementia; NPI: Neuropsychiatric Inventory; GDS-d: Geriatric Depression 
Scale; ZBI: Zarit Burden Interview. 
 
 
 
 
